The response depends on experimental context. Chronic exposure reduced currents in tsA-201 cells, whereas acute exposure did not. In cultured hippocampal neurons, another study reported no impairment of channel trafficking to boutons after seven days of gabapentin exposure. [1,2]
Chronic versus acute calcium-channel current responses
Cell-based study · tsA-201 cells expressing CaV2.1/β4/α2δ-2; binding-site mutant controls R282A-α2δ-2 and CaV2.2/β1b/R217A-α2δ-1. [1]
Chronic gabapentin reduced wild-type channel currents, whereas acute exposure did not. Corresponding binding-site mutants were insensitive to chronic gabapentin. These controls support an α2δ-dependent response in this expression system; they do not establish a universal acute channel-blocking action.
Literature-Reported Treatment Conditions
- Treatment concentration
- 100 μM or 1 mM
- Exposure duration
- Approximately 40 h after transfection for chronic exposure; 10 min for acute 1 mM exposure.
- Method
- Added to culture medium; barium current measured electrophysiologically.
- Vehicle
- Equivalent H2O control.
- Co-treatment
- No combination therapy; channel subunits coexpressed.
- Reported limits
- Detailed culture and recording solutions reside in SI Methods, which was not retrieved; drug supplier/form characterization not recovered from main text.
Methods and source locations
Compound reported in the paper: Gabapentin; Compound label in the paper: GBP
Published gabapentin research; does not validate an Adooq lot, purity, formulation or supplier.
Results: Inhibition of CaV2.1 and CaV2.2 Currents; Prevention by Mutation; Figs 1A,C–E and 2A,C; Statistical Analysis
Reduction of peak IBa at +15 mV relative to matched control: 1 mM GBP for approximately 40 h; Student’s two-tailed t test. — Results first subsection; Fig 1A and caption; Statistical Analysis
Reduction of peak IBa at +15 mV relative to matched control: 100 μM GBP for approximately 40 h; Student’s two-tailed t test. — Results first subsection; Fig 1D–E and caption; Statistical Analysis
Peak current after acute GBP as percentage of its initial value: 1 mM GBP for 10 min; paired temporal comparison; authors report no effect. — Fig 1C caption; Statistical Analysis
Response of binding-site mutant channel combinations to chronic GBP: 1 mM GBP for approximately 40 h; matched H2O controls. No binding-affinity value inferred. — Results: Prevention of the Effect of Chronic GBP; Fig 2A,C captions
Cell-surface channel-subunit localization after chronic exposure
Cell-based study · COS-7 cells expressing CaV2.1–2HA/β4/α2δ-2 (imaging); transfected-cell surface α2δ-2 assessed by biotinylation. [1]
Chronic exposure reduced immunostained surface CaV2.1 and α2δ-2. Orthogonal biotinylation detected a smaller surface fraction of α2δ-2, with intracellular Akt and nonbiotinylated cells serving as controls. The readouts support altered surface abundance, without establishing a specific recycling pathway.
Literature-Reported Treatment Conditions
- Treatment concentration
- 100 μM or 1 mM
- Exposure duration
- Imaging: 48 h culture with GBP; biotinylation: performed 72 h after transfection, with GBP exposure duration not explicitly specified in main text.
- Method
- Culture exposure; nonpermeabilized immunostaining and cell-surface biotinylation/immunoblotting.
- Vehicle
- Control without GBP; H2O used as vehicle in current experiments, but imaging vehicle not separately specified.
- Co-treatment
- No combination therapy.
- Reported limits
- SI Methods not retrieved. Biotinylation GBP incubation duration and drug supplier not recovered; do not transfer the 48 h imaging interval to this assay.
Methods and source locations
Compound reported in the paper: Gabapentin; Compound label in the paper: GBP
Published gabapentin research; does not validate an Adooq lot, purity, formulation or supplier.
Results: Chronic GBP Reduces Plasma Membrane Expression; Fig 3A–D; Methods: Biotinylation Assay and Statistical Analysis
Cell-surface fluorescence per cell area for CaV2.1 and α2δ-2: Nonpermeabilized imaging after 48 h. No signal in nontransfected cells or without primary antibodies (authors’ data not shown). No fluorescence means inferred from bars. — Fig 3A–C captions; Results: Chronic GBP Reduces Plasma Membrane Expression
Reduction in surface α2δ-2 fraction, normalized to whole-cell α2δ-2: Biotinylation/streptavidin pull-down; repeated-measures ANOVA with Bonferroni post hoc test. Akt absent from biotinylated fraction supports membrane integrity. — Fig 3D caption; Methods: Biotinylation Assay and Statistical Analysis
Reported lack of trafficking impairment in hippocampal neurons
Cell-based study · Cultured rat hippocampal CA3–CA1 neurons transfected with eGFP-α1A; presynaptic boutons identified using synapsin staining. [2]
The authors reported no impairment of channel trafficking to boutons with gabapentin. This limits extrapolation of the heterologous-cell trafficking response to all neuronal contexts. Figure S9’s caption and bar ordering disagree on assignment of the two fluorescence means; neither mean nor a numerical effect size is adopted.
Literature-Reported Treatment Conditions
- Treatment concentration
- 1 mM
- Exposure duration
- 7 days (168 h), from transfection at DIV7 to fixation at DIV14.
- Method
- GBP in incubation medium; confocal GFP and synapsin immunofluorescence.
- Vehicle
- Without GBP control; vehicle not specified in selected locations.
- Co-treatment
- No combination therapy.
- Reported limits
- Drug supplier and vehicle not specified in selected locations. Fig S9 group-mean assignment unresolved; no p value stated in S9 caption. n=6 is retained as reported, without inferring neurons/dishes.
Methods and source locations
Compound reported in the paper: Gabapentin; Compound label in the paper: GBP
Published gabapentin research; does not validate an Adooq lot, purity, formulation or supplier.
Main gabapentin Results paragraph and Methods; official Supplementary Information p5, Fig S9
De novo channel trafficking to synaptic boutons after chronic GBP: eGFP-α1A fluorescence at synapsin-positive boutons with versus without 1 mM GBP for 7 days. No equivalence test or numeric group assignment claimed. — Official SI p5 Fig S9 title/caption and images/graph; main gabapentin Results paragraph